Sacramento Metro IV Parole Unit.
Sacramento, California, 95811, United States
NCT Number: NCT01237691
The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Sacramento, California, 95811, United States
The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.
Other names: HOPE, COPE
Parolees are supervised under standard parole supervision practice in California.
Other names: Routine parole
Time frame: 24 months
Total number of days incarcerated in jail or prison
Time frame: 24 months
Percentage of random and scheduled drug tests that test positive for illicit drugs
Time frame: 24 months
Percentage of parole appointments that are missed.
Time frame: 24 months
Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge.
Time frame: 24 months
Number of new arrests.
Time frame: 24 months
Parolees perceived risk of detection for drug use
Pepperdine University
Other
Phase 1 Study of California's HOPE Experiment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06847958
Blood-Borne Infections, Chemically-Induced Disorders
Barcelona, Spain
View Trial DetailsNCT02299921
Alcohol Abuse, Alcohol-Related Disorders
Aurora, Colorado, United States
View Trial DetailsNCT07737652
Anxiety, Anxiety Disorders
Tuscaloosa, Alabama, United States
View Trial DetailsNCT00787423
Chemically-Induced Disorders, Drug Abuse
Baltimore, Maryland, United States
View Trial Details